Replimune (REPL) Accumulated Depreciation (2018 - 2021)
Replimune (REPL) reported Accumulated Depreciation of $2.6 million for Q1 2021, up 182.6% on a YoY basis from $937000.0 in Q1 2020, and up 22.93% sequentially from $2.2 million in Q4 2020.
Replimune (REPL) Accumulated Depreciation (2018 - 2021) Analysis & Trends
Replimune (REPL) has 4 years of Accumulated Depreciation data on file, last reported at $2.6 million in Q1 2021.
- For the quarter ending Q1 2021, Accumulated Depreciation rose 182.6% year-over-year to $2.6 million; the trailing twelve-month figure through Mar 2021 stood at $2.6 million (up 182.6% YoY), and the FY2021 full-year result was $2.6 million, up 182.6% from the prior year.
- Accumulated Depreciation advanced to $2.6 million in Q1 2021, from $2.2 million in the prior quarter.
- In the past five years, Accumulated Depreciation ranged from a high of $2.6 million in Q1 2021 to a low of $256000.0 in Q1 2018.
- A 4-year average of $921846.2 and a median of $488000.0 in 2019 frame the typical range for Accumulated Depreciation.
- Across the five-year window, Accumulated Depreciation jumped 50.15% in 2019 and surged 262.02% in 2020, its largest moves.
- Tracing REPL's Accumulated Depreciation over 4 years: stood at $362000.0 in 2018, then jumped by 64.36% to $595000.0 in 2019, then surged by 262.02% to $2.2 million in 2020, then climbed by 22.93% to $2.6 million in 2021.
- Business Quant data shows REPL's Accumulated Depreciation at $2.6 million in Q1 2021, $2.2 million in Q4 2020, and $1.8 million in Q3 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Replimune | 970.73 Mn | 970.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 2.65 Mn |
| Dec 31, 2020 | 2.15 Mn |
| Sep 30, 2020 | 1.75 Mn |
| Jun 30, 2020 | 1.33 Mn |
| Mar 31, 2020 | 937,000.00 |
| Dec 31, 2019 | 595,000.00 |
| Sep 30, 2019 | 488,000.00 |
| Jun 30, 2019 | 446,000.00 |
| Mar 31, 2019 | 404,000.00 |
| Dec 31, 2018 | 362,000.00 |
| Sep 30, 2018 | 325,000.00 |
| Jun 30, 2018 | 289,000.00 |
| Mar 31, 2018 | 256,000.00 |